Any claim for retatrutide being good for brain health is currently reasoning from a hypothesis, not from human data
The most commonly reported adverse events in the retatrutide groups were gastrointestinal, including nausea, diarrhea, and vomiting
A 2025 article from SHRM reports a notable increase in the average representation of GLP-1 drugs used for weight loss in total annual claims for employers, increasing from 8.9 percent in 2024 to 10.5 percent in 2025
Some people with IBD, especially Crohns disease, also have a condition called small intestinal bacterial overgrowth (SIBO), where there is an excess and imbalance of bacteria in your gut
At 12 months: Comprehensive panel including all baseline tests
(2016) Glutathione as a skin whitening agent: facts, myths, evidence and controversies